BioCirc CCS Komplementarselskab ApS: Financial statements 2025
CVR: 45363767
Source: annual report 2025, Danish Business Authority
23/01/2025 – 31/12/2025
BioCirc CCS Komplementarselskab ApS (CVR 45363767) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -14,600 and a net result of DKK -47,269. Equity in the 2025 report amounted to DKK -7,269.
- Gross Profit
- DKK -14,600
- Profit/Loss
- DKK -47,269
- Equity
- DKK -7,269
- Total Assets
- DKK 206,510
- Employees
- 0
Official annual report
How creditworthy is BioCirc CCS Komplementarselskab ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of July 9, 2025, Thomas Tranekær is registered as director of BioCirc CCS Komplementarselskab ApS.
As of July 9, 2025, Jakob Schiønnemann has stepped down as director of BioCirc CCS Komplementarselskab ApS.
As of January 23, 2025, Kenneth Christian Hansen is registered as director of BioCirc CCS Komplementarselskab ApS.
As of January 23, 2025, Jakob Schiønnemann is registered as director of BioCirc CCS Komplementarselskab ApS.
As of January 23, 2025, BioCirc Group ApS is registered as an owner of BioCirc CCS Komplementarselskab ApS with an ownership share of 100%.
BioCirc CCS Komplementarselskab ApS was founded on January 23, 2025.
About BioCirc CCS Komplementarselskab ApS
BioCirc CCS Komplementarselskab ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2025. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Kenneth Christian Hansen and Thomas Tranekær. The company is owned by BioCirc Group ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -14,600 and a net result of DKK -47,269. Equity in the 2025 report amounted to DKK -7,269.